A mixed methods approach to delineating and understanding injection practices among clientele of a Victoria, British Columbia needle exchange program

Drug and Alcohol Review

Volumn 30, Issue 4, 2011, Pages 360-365

  Gibson, Erin K ^a   Exner, Heidi ^a   Stone, Ryan ^b   Lindquist, Jennifer ^b   Cowen, Laura ^b   Roth, Eric A ^b  

^a AIDS Vancouver Island   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Homelessness; Injection drug user; Injection practice; Needle exchange program

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANADA; COMPREHENSION; DISEASE TRANSMISSION; DRUG ABUSE; FACTUAL DATABASE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; MALE; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT; RISK FACTOR; STATISTICS; SUBSTANCE ABUSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BRITISH COLUMBIA; COMPREHENSION; DATABASES, FACTUAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; RISK FACTORS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79959940471     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2010.00219.x     Document Type: Article

References (23)

1. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse 2006;41:777-813.
2. Institute of Medicine. Preventing HIV infection among injecting drug users in high-risk countries. Washington, D.C.: National Academy Press, 2006.
3. Hagan H, Campbell J, Thiede H, etal. Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. Drug Alcohol Depend 2007;91:S48-55.
4. Wood E, Tyndall M, Spittal P, etal. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange program. AIDS 2004;16:941-3.
5. Exner H, Gibson E, Stone R, Lindquist J, Cowen L, Roth E. Worry as a window into the lives of people who use injection drugs: a factor analysis approach. Harm Reduct J 2009;6:20. doi: 10.1186/1477-7517-6-20.
6. Creswell J, Plank V. Designing and conducting mixed methods research. Thousand Oaks: Sage Publications, 2007.
7. Prata N, Morris L, Mazive E, Vahidnia F, Stehr M. Relationship between HIV risk perception and condom use: evidence from a population-based survey in Mozambique. Int Fam Plan Perspect 2006;32:192-200.
8. Roth E, Ngugi E, Fujita M. Self-deception does not explain high-risk sexual behaviour in the face of HIV/AIDS: a test from northern Kenya. Evol Hum Behav 2006;27:53-62.
9. Allison P. Logistic regression using the SAS® system: theory and applications. Cary: SAS Press, 1996.
10. Vlahov D, Junge B, Brookmeyer R, etal. Reductions in high-risk drug use behaviors among participants in the Baltimore exchange program. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:400-6.
11. Bailey S, DeZheng H, Garfein R, Oulett L. The use of needle exchange by young injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 2003;34:67-70.
12. Huo D, Bailey S, Garfein R, Ouellet L. Changes in the sharing of drug-injection equipment among street-recruited injection drug users in Chicago, Ilinois, 1994-1996. Subst Use Misuse 2005;40:64-76.
13. Strathdee S, Patrick D, Currie S, etal. Needle exchange is not enough: lessons from the Vancouver injection drug use study. AIDS 1997;11:F59-65.
14. Canadian HIV/AIDS Legal Network. Nothing without us: greater meaningful involvement of people who use injection drugs: a public health, ethical and legal human right imperative. Toronto: Canadian HIV/AIDS Legal Network, 2006.
15. Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Policy 2007;18:27-36.
16. Rhodes T, Kimber J, Small W, etal. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction 2006;101:1384-93.
17. DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T. Public injecting among a cohort of injecting drug users in Vancouver, Canada. J Epidemiol Community Health 2009;63:81-6. doi:10.1136/jech.2007.069013.
18. Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh D, Montaner J, Tyndall M. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004;1:9. doi:10.1186/1477-7517-1-9.
19. Wood E, Kerr T, Small W, etal. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ 2004;171:734.
20. Wood E, Kerr T, Li K, Marsh D, Montaner J, Tyndall M. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006;175:1400-4.
21. Wood E, Kerr T, Tyndall M, Montaner J. The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility. Int J Drug Policy 2007;19:220-5.
22. Gabor M. In the realm of the hungry ghosts: close encounters with addiction. Toronto: Knopf Canada, 2008.
23. Agar M. Agents in living color: towards emic agent-based models. JASSS 2005;8:1.